1. Gugliandolo, E., Peritore, A. F., Piras, C., Cuzzocrea, S., & Crupi, R. 2020. Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing. Veterinary sciences, 7(2), 78. https://doi.org/10.3390/vetsci7020078.
2. Di Marzo V. 2008. Endocannabinoids: synthesis and degradation. Reviews of physiology, biochemistry and pharmacology, 160, 1–24. https://doi.org/10.1007/112_0505.
3. Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., & Martin, B. R. 1999. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Current medicinal chemistry, 6(8), 721–744.
4. Gulaya, N. M., Kuzmenko, A. I., Margitich, V. M., Govseeva, N. M., Melnichuk, S. D., Goridko, T. M., & Zhukov, A. D. 1998. Long-chain N-acylethanolamides inhibit lipid peroxidation in rat liver mitochondria under acute hypoxic hypoxia. Chemistry and physics of lipids, 97(1), 49–54. https://doi.org/10.1016/s0009-3084(98)00093-0.
5. Artamonov, M. V., Zhukov, O. D., Horid'ko, T. M., Klimashevs'kyĭ, V. M., Martseniuk, O. P., & Hula, N. M. 2003. Vplyv N-stearoïletanolaminu na lipidni komponenty mikrosom pechinky ta sertsia za diï na shchuriv ionizuiuchoho vyprominiuvannia [Effect of N-stearoylethanolamide and ionizing radiation on lipid components of the liver and heart microsomes in rats]. Ukrains'kyi biokhimichnyi zhurnal (1999 ), 75(4), 81–90.
6. Lykhmus, O., Kalashnyk, O., Uspenska, K., Horid'ko, T., Kosyakova, H., Komisarenko, S., & Skok, M. 2020. Different Effects of Nicotine and N-Stearoyl-ethanolamide on Episodic Memory and Brain Mitochondria of α7 Nicotinic Acetylcholine Receptor Knockout Mice. Biomolecules, 10(2), 226. https://doi.org/10.3390/biom10020226.
7. Artamonov, M., Zhukov, O., Shuba, I., Storozhuk, L., Khmel, T., Klimashevsky, V., Mikosha, A., & Gula, N. 2005. Incorporation of labelled N-acylethanolamide (NAE) into rat brain regions in vivo and adaptive properties of saturated NAE under x-ray irradiation. Ukrains'kyi biokhimichnyi zhurnal (1999 ), 77(6), 51–62.
8. Terrazzino, S., Berto, F., Dalle Carbonare, M., Fabris, M., Guiotto, A., Bernardini, D., & Leon, A. 2004. Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 18(13), 1580–1582. https://doi.org/10.1096/fj.03-1080fje.
9. Hula, N. M., Chumak, A. A., Berdyshev, A. H., Mehed', O. F., Horid'ko, T. M., Kindruk, N. L., Kosiakova, H. V., & Zhukov, O. D. 2009. Ukrains'kyi biokhimichnyi zhurnal (1999 ), 81(2), 107–116.
10. Onopchenko, O. V., Kosiakova, G. V., Klimashevsky, V. M., & Hula, N. M. 2015. The effect of N-stearoylethanolamide on plasma lipid composition in rats with experimental insulin resistance. Ukrainian biochemical journal, 87(1), 46–54.
11. Baldwin A. S., Jr. 2001. Series introduction: the transcription factor NF-kappaB and human disease. The Journal of clinical investigation, 107(1), 3–6. https://doi.org/10.1172/JCI11891.
12. Cheah, F. C., Hampton, M. B., Darlow, B. A., Winterbourn, C. C., & Vissers, M. C. 2005. Detection of apoptosis by caspase-3 activation in tracheal aspirate neutrophils from premature infants: relationship with NF-kappaB activation. Journal of leukocyte biology, 77(3), 432–437. https://doi.org/10.1189/jlb.0904520.
13. Cowburn, A. S., Deighton, J., Walmsley, S. R., & Chilvers, E. R. 2004. The survival effect of TNF-alpha in human neutrophils is mediated via NF-kappa B-dependent IL-8 release. European journal of immunology, 34(6), 1733–1743. https://doi.org/10.1002/eji.200425091.
14. Siednienko, J., & Gorczyca, W. A. 2003. Regulacja aktywności NF-kappa B [Regulation of NF-kappa B activity]. Postepy higieny i medycyny doswiadczalnej, 57(1), 19–32.
15. Berdyshev, A. G., Kosiakova, H. V., Onopchenko, O. V., Panchuk, R. R., Stoika, R. S., & Hula, N. M. 2015. N-Stearoylethanolamide suppresses the pro-inflammatory cytokines production by inhibition of NF-κB translocation. Prostaglandins & other lipid mediators, 121(Pt A), 91–96. https://doi.org/10.1016/j.prostaglandins.2015.05.001.
16. Scirpo, R., Fiorotto, R., Villani, A., Amenduni, M., Spirli, C., & Strazzabosco, M. 2015. Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology (Baltimore, Md.), 62(5), 1551–1562. https://doi.org/10.1002/hep.28000.
17. Ruan, H., Pownall, H. J., & Lodish, H. F. 2003. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. The Journal of biological chemistry, 278(30), 28181–28192. https://doi.org/10.1074/jbc.M303141200
18. Hula, N. M., Chumak, A. A., Mehed', O. F., Horid'ko, T. M., Kindruk, N. L., & Berdyshev, A. H. 2008. Ukrains'kyi biokhimichnyi zhurnal (1999), 80(1), 57–67.
19 [1]. Lykhmus, O., Uspenska, K., Koval, L., Lytovchenko, D., Voytenko, L., Horid'ko, T., Kosiakova, H., Gula, N., Komisarenko, S., & Skok, M. 2017. N-Stearoylethanolamide protects the brain and improves memory of mice treated with lipopolysaccharide or immunized with the extracellular domain of α7 nicotinic acetylcholine receptor. International immunopharmacology, 52, 290–296. https://doi.org/10.1016/j.intimp.2017.09.023.
20. Epps, D. E., Natarajan, V., Schmid, P. C., & Schmid, H. O. 1980. Accumulation of N-acylethanolamide glycerophospholipids in infarcted myocardium. Biochimica et biophysica acta, 618(3), 420–430. https://doi.org/10.1016/0005-2760(80)90260-x.
21. Sancho, R., Calzado, M. A., Di Marzo, V., Appendino, G., & Muñoz, E. 2003. Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway. Molecular pharmacology, 63(2), 429–438. https://doi.org/10.1124/mol.63.2.429.
22. Peritore, A. F., Siracusa, R., Crupi, R., & Cuzzocrea, S. 2019. Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets. Nutrients, 11(9), 2175. https://doi.org/10.3390/nu11092175.
23. Berdyshev A.G., Kosiakova H.V., Hula N.M. 2017. Modulation of LPS-induced ROS production and NF-κB nuclear translocation by N-stearoylethanolamide in macrophages. Ukrains'kyi biokhimichnyi zhurnal (1999 ), 89(5), 62–69.
24. Heming, M., Gran, S., Jauch, S. L., Fischer-Riepe, L., Russo, A., Klotz, L., Hermann, S., Schäfers, M., Roth, J., & Barczyk-Kahlert, K. 2018. Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids. Frontiers in immunology, 9, 893. https://doi.org/10.3389/fimmu.2018.00893.
25. Wang, J., Xiao, C., Wei, Z., Wang, Y., Zhang, X., & Fu, Y. 2018. Activation of liver X receptors inhibit LPS-induced inflammatory response in primary bovine mammary epithelial cells. Veterinary immunology and immunopathology, 197, 87–92. https://doi.org/10.1016/j.vetimm.2018.02.002.
26. Scirpo, R., Fiorotto, R., Villani, A., Amenduni, M., Spirli, C., & Strazzabosco, M. 2015. Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology (Baltimore, Md.), 62(5), 1551–1562. https://doi.org/10.1002/hep.28000.
27. Scirpo, R., Fiorotto, R., Villani, A., Amenduni, M., Spirli, C., & Strazzabosco, M. 2015. Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology (Baltimore, Md.), 62(5), 1551–1562. https://doi.org/10.1002/hep.28000.
28. Nakanishi, A., & Tsukamoto, I. 2015. n-3 polyunsaturated fatty acids stimulate osteoclastogenesis through PPARγ-mediated enhancement of c-Fos expression, and suppress osteoclastogenesis through PPARγ-dependent inhibition of NFkB activation. The Journal of nutritional biochemistry, 26(11), 1317–1327. https://doi.org/10.1016/j.jnutbio.2015.06.007.
29. Grygiel-Górniak B. 2014. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review. Nutrition journal, 13, 17. https://doi.org/10.1186/1475-2891-13-17.
30. Shysh, A. M., Nagibin, V. S., Kaplinskii, S. P., & Dosenko, V. E. 2016. N-3 long chain polyunsaturated fatty acids increase the expression of PPARγ-target genes and resistance of isolated heart and cultured cardiomyocytes to ischemic injury. Pharmacological reports : PR, 68(6), 1133–1139. https://doi.org/10.1016/j.pharep.2016.06.013.
31. Martin, G., Schoonjans, K., Lefebvre, A. M., Staels, B., & Auwerx, J. 1997. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. The Journal of biological chemistry, 272(45), 28210–28217. https://doi.org/10.1074/jbc.272.45.28210.
32. Meier, C. A., Chicheportiche, R., Juge-Aubry, C. E., Dreyer, M. G., & Dayer, J. M. 2002. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma. Cytokine, 18(6), 320–328. https://doi.org/10.1006/cyto.2002.1945.
33. Balvers, M. G., Verhoeckx, K. C., Meijerink, J., Wortelboer, H. M., & Witkamp, R. F. 2013. Measurement of palmitoylethanolamide and other N-acylethanolamides during physiological and pathological conditions. CNS & neurological disorders drug targets, 12(1), 23–33. https://doi.org/10.2174/1871527311312010007.